Clinical Trial Update: Vortioxetine for Menopausal Depression [Phase 4]

View source ↗

Summary

Phase 4 trial of vortioxetine for menopausal depression completed with results posted in May 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Menopause

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Menopause | Phase 4 | Status: COMPLETED | Results posted: 2017-05-02